Storm of protest against nod for more Bt crops
"NEW DELHI, HYDERABAD, APRIL 17: Farmers' groups and civil society organisations across the country have expressed deep concerns over the country's regulatory authority approving new biotech (Bt) cotton hybrids for cultivation in new areas when the case for extension of the approval period for three such varieties under cultivation has become controversial.
"As part of the Global Week of Action (GWA) being celebrated worldwide, several civil society and farmers' groups have stepped up the campaign against 'unwarranted approval of new Bt cotton hybrids, when the case for old varieties remains undecided.' ...
"Some civil society groups have conducted scientific studies, which show the failure of Bt cotton in south India. The Secunderabad-based Centre for Sustainable Agriculture (CSA) conducted a study under the leadership of Dr GV Ramanjaneyulu and entomologist Dr SMA Ali, which showed the failure of Bt cotton in Warangal and Medak districts of Andhra Pradesh. A similar study conducted by Dr Abdul Qayum and Kiran Sakkhari on behalf of the Deccan Development Society (DDS), Andhra Pradesh Coalition in Defence of Diversity and Permaculture Association of India bared farmers suffering from heavy losses on account of Bt cotton cultivation. The district authority of Warangal has asked Mahyco Monsanto to compensate the farmers for the losses.
"Also, studies conducted by the Gene Campaign, Research Foundation for Science, Technology and Ecology and Greenpeace India have shown the failure of Bt cotton in Andhra Pradesh, Karnataka and Tamil nadu. Eminent scientist and Padma Bhushan awardee Dr Pushpa M Bhargava has gone on record saying that Bt cotton has failed to live up to expectations. So far, only one survey which was conducted by an advertising and market research agency, IMRB on behalf on Monsanto India has attested to the success of Bt cotton cultivation. However, the CSA has refuted point-by-point the survey conducted by IMRB."
Source: financialexpress.com
"NEW DELHI, HYDERABAD, APRIL 17: Farmers' groups and civil society organisations across the country have expressed deep concerns over the country's regulatory authority approving new biotech (Bt) cotton hybrids for cultivation in new areas when the case for extension of the approval period for three such varieties under cultivation has become controversial.
"As part of the Global Week of Action (GWA) being celebrated worldwide, several civil society and farmers' groups have stepped up the campaign against 'unwarranted approval of new Bt cotton hybrids, when the case for old varieties remains undecided.' ...
"Some civil society groups have conducted scientific studies, which show the failure of Bt cotton in south India. The Secunderabad-based Centre for Sustainable Agriculture (CSA) conducted a study under the leadership of Dr GV Ramanjaneyulu and entomologist Dr SMA Ali, which showed the failure of Bt cotton in Warangal and Medak districts of Andhra Pradesh. A similar study conducted by Dr Abdul Qayum and Kiran Sakkhari on behalf of the Deccan Development Society (DDS), Andhra Pradesh Coalition in Defence of Diversity and Permaculture Association of India bared farmers suffering from heavy losses on account of Bt cotton cultivation. The district authority of Warangal has asked Mahyco Monsanto to compensate the farmers for the losses.
"Also, studies conducted by the Gene Campaign, Research Foundation for Science, Technology and Ecology and Greenpeace India have shown the failure of Bt cotton in Andhra Pradesh, Karnataka and Tamil nadu. Eminent scientist and Padma Bhushan awardee Dr Pushpa M Bhargava has gone on record saying that Bt cotton has failed to live up to expectations. So far, only one survey which was conducted by an advertising and market research agency, IMRB on behalf on Monsanto India has attested to the success of Bt cotton cultivation. However, the CSA has refuted point-by-point the survey conducted by IMRB."
Source: financialexpress.com
Pip Wilson posted item above at 9:53 AM | Permalink
0 Comments:
Post a Comment
<< Home